Literature DB >> 2265769

Measurements of antifungal levels in corneal tissue: a simplified bioassay for amphotericin B.

T E Williams1, D M O'Day, W S Head, R D Robinson.   

Abstract

Measuring precise antifungal levels in the cornea with broth-dilution bioassays is difficult, as standard techniques involving visual determination of endpoints are hindered by corneal debris. To increase the precision of the measurement, we modified the sample preparation for bioassay of rabbit corneas treated with subconjunctival amphotericin B. Endpoint determination and variance were compared for a freshly thawed corneal suspension and the supernatant after 24 h equilibration; bioassay of the corneal suspension after 24 h equilibration served as an additional control. All endpoints were read visually in a masked fashion and were verified by culture. The three methods gave comparable endpoint values with equivalent degrees of variance. Amphotericin B levels were consistent by both visual and culture determination; however, endpoints were clearly visible and easier to read for the supernatant. Visual determination of the endpoints for the supernatant following 24 h equilibration simplified and ensured the precision of the bioassay technique.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2265769     DOI: 10.1007/bf00918487

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  2 in total

Review 1.  Selection of appropriate antifungal therapy.

Authors:  D M O'Day
Journal:  Cornea       Date:  1987       Impact factor: 2.651

2.  Bioavailability and penetration of topical amphotericin B in the anterior segment of the rabbit eye.

Authors:  D M O'Day; W S Head; R D Robinson; J A Clanton
Journal:  J Ocul Pharmacol       Date:  1986
  2 in total
  1 in total

1.  Toxicities and pharmacokinetics of subconjunctival injection of liposomal amphotericin B.

Authors:  Yuichi Kaji; Erika Yamamoto; Takahiro Hiraoka; Tetsuro Oshika
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-29       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.